Skip to main content
. 2018 Aug 19;68(5):813–822. doi: 10.1007/s00262-018-2229-6

Fig. 1.

Fig. 1

Maximum Intensity Projection Images (MIP) 18F-FDG PET–CT images in a patient with advanced melanoma prior to ICI, after two and four cycles of pembrolizumab and after a combined ipilimumab/nivolumab therapy. 18F-FDG PET–CT clearly demonstrated progression with new lesions in every follow-up study